will meet with federal health officials as soon as Monday to discuss the need for a booster dose of the coronavirus vaccine as it prepares to seek authorization, the company said on Sunday.announced plans to seek U.S. and European regulatory approval for a third dose of their COVID-19 shot amid the spread of variants and data they said showed heightened risk of infection six months after initial inoculation.
Representatives for the U.S. Department of Health and Human Services did not immediately respond to a request for comment. Fauci, in several television interviews on Sunday, said U.S. health officials were not dismissing the possible future need for boosters -- especially as breakthrough infections among those who have been vaccinated have emerged -- but that more data is needed for any formal recommendation."There are studies being done now ongoing as we speak about looking at the feasibility about if and when we should be boosting people...
If the unit price for each shot remains the same the firm will earn 50% more than it earned on a 2-shot regime. Not a bad business venture at all, go for it Pfizer, go for the tax payers jugular.
For all those who are new to this working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick to him RonelMoses32 Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success⚖️